Lupin’s partner ForDoz receives USFDA approval for doxorubicin hydrochloride liposome injection
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
The pooled prevalence of GERD in the Indian population is 15.6 %
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols
Subscribe To Our Newsletter & Stay Updated